已發(fā)表論文28篇，總引次數(shù)超1500，H指數(shù)19；其中，以第一（含共一）或通訊作者發(fā)表論文12篇，累計被引超900次；授權(quán)專利2項。

代表性論文：

1. Li Y#, Bai L#, Yu H, Cai D, Wang X, Huang B, Peng S, Huang M, Cao G, Kaz AM, Grady WM, Wang J, and Luo Y*. Epigenetic inactivation of α-internexin accelerates microtubule polymerization in colorectal cancer. Cancer Res. 2020; 80(23):5203-15.
2. Zhu?M#, Bai?L#, Liu?X#, Peng?S, Xie?Y, Bai?H, Yu?H, Wang?X, Lin?J, Wu?L, Huang?M, Li?Y*, Luo?Y*. Silence of dependence receptor CSF1R activates tumor-associated macrophages in colorectal cancer. J ImmunoTher Cancer. 2022; 10:e005610.
3. Li?Y#, Lei?Y#, Yao?N, Wang?C, Hu?N, Ye?W, Zhang?D* and Chen?Z*. Autophagy and multidrug resistance in cancer. Cancer Commun. 2017; 36(1): 52.
4. Bai?L#, Wu?L#, Zhang?C, Liu?Z, Ma?L, Ni?J, He?D, Zhu?M, Peng?S, Liu?X, Yu?H, Lei?Y, Luo?Y, Zhang?Y, Wang?X*, Wei?G*, Li?Y*. Replenishment of mitochondrial Na+?and H+?by ionophores potentiates cutaneous wound healing in diabetes. Materials Today Bio. 2024; 26 (2024) 101056.
5. Yao N#, Li Y#, Lei Y#, Hu N, Chen W, Yao Z, Yu M, Liu J, Ye W* and Zhang D*. A piperazidine derivative of 23-hydroxy betulinic acid induces a mitochondria-derived ROS burst to trigger apoptotic cell death in hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2016; 35(1): 192.
6. Peng S#, Li Y#, Huang M, Tang G, Xie Y, Chen D, Hu Y, Yu T, Cai J, Yuan Z, Wang H, Wang H, Luo Y*, Liu X*. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity. Int J Biol Sci. 2022; 18(5):1912-1932
7. Lei Y#, Zhang E#, Bai L*, Li Y*. Autophagy in cancer immunotherapy. Cells. 2022. 11 (19) :2996
8. Liu D#, Li Y#, Yang D, Wang C, Xu J, Yao N, Zhang X, Chen Z, Ye W*?and Zhang DM*. Ganoderma lucidum derived ganoderenic acid B reverses ABCB1-mediated multidrug resistance in HepG2/ADM cells. Int J?Oncol. 2015; 46(5): 2029-38.
9. 
   Liu D#, Li Y#, Yao N, Xu J, Chen Z, Yiu A, Zhang C, Ye W*, Zhang D*. Acerinol, a cyclolanstane triterpenoid from Cimicifuga acerina, reverses ABCB1-mediated multidrug resistance in HepG2/ADM and MCF-7/ADR cells. Eur J Pharmacol. 2014; 733C: 34-44.

代表性專利：

一類化合物促皮膚損傷修復(fù)的用途. 中國發(fā)明專利. ZL202010566166.5,?第一發(fā)明人

化合物促皮膚損傷修復(fù)的用途. 中國發(fā)明專利. ZL202111044412.1,?第一發(fā)明人